Articles with public access mandates - Grazia GrazianiLearn more
Not available anywhere: 4
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive …
PM Lacal, G Graziani
Pharmacological research 136, 97-107, 2018
Mandates: Government of Italy
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma
PM Lacal, MG Atzori, F Ruffini, M Scimeca, E Bonanno, R Cicconi, ...
Pharmacological research 159, 104957, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine …
L Tentori, A Muzi, AS Dorio, M Scarsella, C Leonetti, GM Shah, W Xu, ...
Current cancer drug targets 10 (4), 368-383, 2010
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Poly (ADP-Ribose) polymerase inhibitors for arsenic trioxide–resistant acute promyelocytic leukemia: Synergistic in vitro antitumor effects with hypomethylating agents or high …
M Giansanti, A De Gabrieli, SP Prete, T Ottone, MD Divona, T Karimi, ...
Journal of Pharmacology and Experimental Therapeutics 377 (3), 385-397, 2021
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Available somewhere: 45
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
E Eskilsson, GV Røsland, G Solecki, Q Wang, PN Harter, G Graziani, ...
Neuro-oncology 20 (6), 743-752, 2018
Mandates: Research Council of Norway
Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid
C Ceci, PM Lacal, L Tentori, MG De Martino, R Miano, G Graziani
Nutrients 10 (11), 1756, 2018
Mandates: Government of Italy
Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models
C Ceci, MG Atzori, PM Lacal, G Graziani
International journal of molecular sciences 21 (4), 1388, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
E Eskilsson, GV Rosland, KM Talasila, S Knappskog, O Keunen, ...
Neuro-oncology 18 (12), 1644-1655, 2016
Mandates: Research Council of Norway
PARP-1 modulates amyloid beta peptide-induced neuronal damage
S Martire, A Fuso, D Rotili, I Tempera, C Giordano, I De Zottis, A Muzi, ...
PLoS One 8 (9), e72169, 2013
Mandates: Government of Italy
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
GR Tundo, D Sbardella, AM Santoro, A Coletta, F Oddone, G Grasso, ...
Pharmacology & therapeutics 213, 107579, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Neuropilin-1 as therapeutic target for malignant melanoma
G Graziani, PM Lacal
Frontiers in oncology 5, 125, 2015
Mandates: Government of Italy
Pharmacological inhibition of poly (ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
L Tentori, L Ricci-Vitiani, A Muzi, F Ciccarone, F Pelacchi, R Calabrese, ...
BMC cancer 14, 1-12, 2014
Mandates: Government of Italy
Saffron and its major ingredients’ effect on colon cancer cells with mismatch repair deficiency and microsatellite instability
A Amin, A Farrukh, C Murali, A Soleimani, F Praz, G Graziani, H Brim, ...
Molecules 26 (13), 3855, 2021
Mandates: US National Institutes of Health
Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic melanoma
C Ceci, MG Atzori, PM Lacal, G Graziani
Cancers 12 (11), 3401, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Cilengitide downmodulates invasiveness and vasculogenic mimicry of neuropilin 1 expressing melanoma cells through the inhibition of αvβ5 integrin
F Ruffini, G Graziani, L Levati, L Tentori, S D'Atri, PM Lacal
International journal of cancer 136 (6), E545-E558, 2015
Mandates: Government of Italy
Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
MG Atzori, C Ceci, F Ruffini, M Trapani, ML Barbaccia, L Tentori, S D'Atri, ...
Journal of cellular and molecular medicine 24 (1), 465-475, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
L Lisi, PM Lacal, ML Barbaccia, G Graziani
Biochemical pharmacology 180, 114169, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
On the horizon: targeting next-generation immune checkpoints for cancer treatment
GR Tundo, D Sbardella, PM Lacal, G Graziani, S Marini
Chemotherapy 64 (2), 62-80, 2019
Mandates: Government of Italy
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness
F Ruffini, L Tentori, AS Dorio, D Arcelli, G D'Amati, S D'Atri, G Graziani, ...
Oncology reports 30 (6), 2887-2896, 2013
Mandates: Government of Italy
Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness
E Pagani, F Ruffini, GCA Cappellini, A Scoppola, C Fortes, P Marchetti, ...
International Journal of Oncology 48 (4), 1581-1589, 2016
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program